FP532THE PROGNOSTIC VALUE OF NEPHRO-CARDIAC BIOMARKERS IN HEMODIALYSIS PATIENTS - THE RANDOMIZED-CONTROLLED MIRENDA TRIAL. (18th May 2018) - Hauser, T; Malzahn, U; Betz, C; Grupp, C; Doeltz, T; Grebe, S; Murillo, E; Bausch, S; Störk, S; Krane, V; Hammer, F; Wanner, C